about
Flupirtine, a re-discovered drug, revisited.Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions.Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.Comparative evaluation of oral flupirtine and oral diclofenac sodium for analgesia and adverse effects in elective abdominal surgeriesEvidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier k(+) currents in motor neuron-like cells.Effect of preoperative flupirtine on postoperative morphine sparing in patients undergoing total abdominal hysterectomy.Effect of flupirtine on the growth and viability of U373 malignant glioma cells.Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats.Potential drug therapies for the treatment of fibromyalgia.The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, neuroprotection and angioneurogenesis.Dependence on flupirtine.Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions.An update on emerging drugs for fibromyalgia treatment.Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-Cell Lymphoma 2 (Bcl-2).
P2860
Q34322776-23DCA0E7-7383-462B-8862-278690FCE946Q34371285-4C3F1835-047D-4C4B-BC10-6FD090BEA13CQ35135974-4E8B2853-E542-4A91-B749-3995FF628A22Q35247955-88211FD6-5652-4624-8D57-041F8BEEA728Q36129188-2EFE7F33-8AEA-450A-8F82-B290B52AAEEFQ36596743-5A59AD5F-A3D7-46D9-83C3-D6DFC8DA4A67Q37386230-9564816B-8088-4536-B56C-9EAABA295841Q37589301-8DEEC215-7648-49FE-920A-343D79637E89Q38857241-40E6A5EB-69B1-4504-8CAD-06F3E50D8E17Q42269178-BC15AF28-D4BA-45CD-BFF1-57D8506C35EDQ43433635-2EC8F5DB-1BDF-4A31-9898-D5056FCB9B2EQ47111029-FC108F6A-BD70-4708-8195-9F40021D9AFEQ47292988-3C34D55F-E423-4FE8-A3E6-7AA0EBAB26F0Q47432782-6C3CD174-7642-4DCB-88A2-485AA71E2656
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Flupirtine: Clinical pharmacology
@ast
Flupirtine: Clinical pharmacology
@en
Flupirtine: Clinical pharmacology
@nl
type
label
Flupirtine: Clinical pharmacology
@ast
Flupirtine: Clinical pharmacology
@en
Flupirtine: Clinical pharmacology
@nl
prefLabel
Flupirtine: Clinical pharmacology
@ast
Flupirtine: Clinical pharmacology
@en
Flupirtine: Clinical pharmacology
@nl
P2093
P2860
P356
P1476
Flupirtine: Clinical pharmacology
@en
P2093
Girish M Bengalorkar
P2860
P304
P356
10.4103/0970-9185.94833
P577
2012-04-01T00:00:00Z